Avacta Group plc, the developer of Affimer ® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global ...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "ELISA Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The ...

Scientists say they have developed a new computational method to reduce variability in common research biomarker tests. They see their techniques as a promising step in improving the ability of ...

A desire for a simpler, cheaper way to do common laboratory tests for medical diagnoses and to avoid 'washing the dishes' led researchers to develop a new technology that reduces cost and time. The 3D ...

Enzyme-linked immunosorbent assays (ELISAs) represent the gold standard for quantitatively detecting protein biomarkers, and are used for applications such as diagnosing or monitoring disease, ...

Lucknow: A state-level training of lab technicians and non-medical scientists on Elisa-based testing for lab diagnosis of dengue and chikungunya was held at SGPGIMS. Anchored by the Viral Research and ...